Cargando…

84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA

ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Ric...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Rivera, Enid, Ruiz, Krystel, Miranda, Edgar, Mejã, Luis, Marques, Cecile, Quijada, José, Monsanto, Homero, Orengo, Juan, Pinzón, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827741/
http://dx.doi.org/10.1017/cts.2021.488
_version_ 1784647700646461440
author Garcia-Rivera, Enid
Ruiz, Krystel
Miranda, Edgar
Mejã, Luis
Marques, Cecile
Quijada, José
Monsanto, Homero
Orengo, Juan
Pinzón, Adolfo
author_facet Garcia-Rivera, Enid
Ruiz, Krystel
Miranda, Edgar
Mejã, Luis
Marques, Cecile
Quijada, José
Monsanto, Homero
Orengo, Juan
Pinzón, Adolfo
author_sort Garcia-Rivera, Enid
collection PubMed
description ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Rico. METHODS/STUDY POPULATION: This is a descriptive study using healthcare claims data from patients with T2DM (based on ICD-9 diagnosis code) from most public and private healthcare insurance companies providing services in Puerto Rico in 2013 (representing more than 90% of insured population). Descriptive analyses by age, sex, type of insurance, health region, and type of medical encounter were done using frequency and percent for categorical data or means or median (with corresponding standard deviation or interquartile range) for continuous variables RESULTS/ANTICIPATED RESULTS: A total of 3,100,636 claims were identified from 485,866 adult patients with T2DM. Most patients were women (276,400; 57%), older than 65 years (235,390; 48%), from the Puerto Rico health regions of Caguas (79,604; 16%), Metro (66,280; 14%), or Bayamon (62,673; 13%) with private health insurance (371,806; 77%). The number of claims per patient ranged from 1 to 339. A mean of 6.3 claims (SD ±9.99) and a median of 3 claims (Q1 1- Q3 8) per subject were identified. Most (74%) were related to the diagnosis of diabetes (1,829,2015; 59%) or to cardiovascular diseases (458,219; 15%) and associated to outpatient services (2,722,727; 88%). The most prevalent comorbidities were hypertension (235,277; 48%), hyperlipidemia (197,449; 41%), neuropathy (100,471; 21%); renal disease (71,517; 15%), and retinopathy (61,837; 13%) DISCUSSION/SIGNIFICANCE OF FINDINGS: A high prevalence of comorbidities and use of healthcare services were identified in patients with T2DM, especially in older adults. Most comorbidities were due to diabetes-related conditions, highlighting the importance of early diagnosis and adequate management of T2DM patients to avoid preventable burden to the patient and the healthcare system
format Online
Article
Text
id pubmed-8827741
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88277412022-02-28 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA Garcia-Rivera, Enid Ruiz, Krystel Miranda, Edgar Mejã, Luis Marques, Cecile Quijada, José Monsanto, Homero Orengo, Juan Pinzón, Adolfo J Clin Transl Sci Clinical Epidemiology ABSTRACT IMPACT: Summarize the burden of diabetes comorbidities and its impact in healthcare utilization in Puerto Rico OBJECTIVES/GOALS: To estimate the prevalence of common comorbidities and describe the healthcare utilization patterns in patients with type 2 diabetes mellitus (T2DM) in Puerto Rico. METHODS/STUDY POPULATION: This is a descriptive study using healthcare claims data from patients with T2DM (based on ICD-9 diagnosis code) from most public and private healthcare insurance companies providing services in Puerto Rico in 2013 (representing more than 90% of insured population). Descriptive analyses by age, sex, type of insurance, health region, and type of medical encounter were done using frequency and percent for categorical data or means or median (with corresponding standard deviation or interquartile range) for continuous variables RESULTS/ANTICIPATED RESULTS: A total of 3,100,636 claims were identified from 485,866 adult patients with T2DM. Most patients were women (276,400; 57%), older than 65 years (235,390; 48%), from the Puerto Rico health regions of Caguas (79,604; 16%), Metro (66,280; 14%), or Bayamon (62,673; 13%) with private health insurance (371,806; 77%). The number of claims per patient ranged from 1 to 339. A mean of 6.3 claims (SD ±9.99) and a median of 3 claims (Q1 1- Q3 8) per subject were identified. Most (74%) were related to the diagnosis of diabetes (1,829,2015; 59%) or to cardiovascular diseases (458,219; 15%) and associated to outpatient services (2,722,727; 88%). The most prevalent comorbidities were hypertension (235,277; 48%), hyperlipidemia (197,449; 41%), neuropathy (100,471; 21%); renal disease (71,517; 15%), and retinopathy (61,837; 13%) DISCUSSION/SIGNIFICANCE OF FINDINGS: A high prevalence of comorbidities and use of healthcare services were identified in patients with T2DM, especially in older adults. Most comorbidities were due to diabetes-related conditions, highlighting the importance of early diagnosis and adequate management of T2DM patients to avoid preventable burden to the patient and the healthcare system Cambridge University Press 2021-03-30 /pmc/articles/PMC8827741/ http://dx.doi.org/10.1017/cts.2021.488 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Epidemiology
Garcia-Rivera, Enid
Ruiz, Krystel
Miranda, Edgar
Mejã, Luis
Marques, Cecile
Quijada, José
Monsanto, Homero
Orengo, Juan
Pinzón, Adolfo
84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title_full 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title_fullStr 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title_full_unstemmed 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title_short 84617 Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus living in Puerto Rico, USA
title_sort 84617 prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus living in puerto rico, usa
topic Clinical Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827741/
http://dx.doi.org/10.1017/cts.2021.488
work_keys_str_mv AT garciariveraenid 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT ruizkrystel 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT mirandaedgar 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT mejaluis 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT marquescecile 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT quijadajose 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT monsantohomero 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT orengojuan 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa
AT pinzonadolfo 84617prevalenceandcoprevalenceofcomorbiditiesamongpatientswithtype2diabetesmellituslivinginpuertoricousa